Syschem (India) Ltd (SYSCHEM)

BSE · Healthcare · Pharmaceuticals & Biotechnology · Pharmaceuticals

₹33.25

As of 30 Oct 2026 close.

Facts from reported results and exchange filings. Not investment advice.

Share price

Prices load here as you scroll to them.

Last close ₹33.25 on 30 Oct 2026. The share price traded between ₹28.81 and ₹60.95 (intraday) over the last 12 months.

The closes as a table

DateClose

Key figures

1-year range (intraday)

Last close ₹33.25

Low ₹28.81High ₹60.95

Market cap₹178 crorelast close × shares
P/E24.8on reported profit, last four quarters
Profit, last 12 months₹7.19 crto shareholders
Profit incl. minorities₹6.00 crlast 12 months
Return on equity10.2%year to Mar 2026
EBITDA margin3.7%year to Mar 2026
Debt to equity0.01year to Mar 2026
Net margin1.9%year to Mar 2026
Dividend yieldnonelast 12 months

Price trend

Revenue and profit

RevenueNet profit₹ crore
-2000200400600
YearMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Revenue59114199332574
Net profit-253011
EBITDA margin0.9%8.0%3.5%1.2%3.7%
Borrowings22000

₹ crore. Over three years, compounded: revenue grew 71.4% a year, net profit grew 30.1% a year.

Recent filings

Questions about Syschem (India) Ltd

What is Syschem (India) Ltd's market value?

Syschem (India) Ltd's market value is ₹178 crore as of 30 Oct 2026 close: the last close times the shares in issue. Its P/E is 24.8, the last close over earnings per share for the last four reported quarters.

Go further with SYSCHEM

Free to start: test a trading idea on SYSCHEM's real prices after costs, or open the full deep dive with ten years of numbers, red flags and management's record.

Same industry

The largest companies in the same industry (Pharmaceuticals), by market value.

Browse companies

The companies before and after this one, A to Z, and the lists it is in.

How these figures are worked out

P/E 24.8 is the close over earnings per share, the profit that belongs to the company's shareholders (market cap divided by P/E: 7 crore for the last 12 months, shown above). The net profit including the share owned by minority shareholders of subsidiaries is 6 crore; market cap divided by that gives 29.7. The last 12 months are the four latest reported quarters, so their profit can differ from the newest year's in the table below.